Cargando…

Comparison of Weight-Gain-Based Prediction Models for Retinopathy of Prematurity in an Australian Population

PURPOSE: Four weight-gain-based algorithms are compared for the prediction of type 1 ROP in an Australian cohort: the weight, insulin-like growth factor, neonatal retinopathy of prematurity (WINROP) algorithm, the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOPROP), the Col...

Descripción completa

Detalles Bibliográficos
Autores principales: Bremner, Alexander, Chan, Li Yen, Jones, Courtney, Shah, Shaheen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477029/
https://www.ncbi.nlm.nih.gov/pubmed/37670799
http://dx.doi.org/10.1155/2023/8406287
Descripción
Sumario:PURPOSE: Four weight-gain-based algorithms are compared for the prediction of type 1 ROP in an Australian cohort: the weight, insulin-like growth factor, neonatal retinopathy of prematurity (WINROP) algorithm, the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOPROP), the Colorado Retinopathy of Prematurity (CO-ROP) algorithm, and the postnatal growth, retinopathy of prematurity (G-ROP) algorithm. METHODS: A four-year retrospective cohort analysis of infants screened for ROP in a tertiary neonatal intensive care unit in Brisbane, Australia. The main outcome measures were sensitivities, specificities, and positive and negative predictive values. RESULTS: 531 infants were included (mean gestational age 28 + 3). 24 infants (4.5%) developed type 1 ROP. The sensitivities, specificities, and negative predictive values, respectively, for type 1 ROP (95% confidence intervals) were for WINROP 83.3% (61.1–93.3%), 52.3% (47.8–56.7%), and 98.4% (96.1–99.4%); for CHOPROP 100% (86.2–100%), 46.0% (41.7–50,3%), and 100% (98.4–100%); for CO-ROP 100% (86.2–100%), 32.0% (28.0%–36.1%), and 100% (98.3–100%); and for G-ROP 100% (86.2–100%), 28.2% (24.5–32.3%), and 100% (97.4–100%). Of the five infants with persistent nontype 1 ROP that underwent treatment, only CO-ROP was able to successfully identify all. CONCLUSIONS: CHOPROP, CO-ROP, and G-ROP performed well in this Australian population. CHOPROP, CO-ROP, and G-ROP would reduce the number of infants requiring examinations by 43.9%, 30.5%, and 26.9%, respectively, compared to current ROP screening guidelines. Weight-gain-based algorithms would be a useful adjunct to the current ROP screening.